Lymphocyte Transformation Test is unreliable for the diagnosis of kampo-medicine-induced liver injury.

淋巴细胞转化试验对于汉方药引起的肝损伤的诊断并不可靠。

基本信息

  • 批准号:
    15590596
  • 负责人:
  • 金额:
    $ 0.51万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

To examine actual impact of mitogenic activity by Kampo medicine on the lymphocyte transformation test(LTT), we conducted LTT for four herbs in patients who had taken no Kampo medicine in their life and consulted our department for the first time. Fourteen patients were enrolled for Toki (Angelicae Radix) and Ogon (Scutellariae Radix), and 4 patients were enrolled for Saiko (Bupleuri Radix) and Kanzo (Glycyrrhizae Radix). Patients who were being treated with corticosteroids or immunosuppresive drugs or who had experienced drug allergy were excluded. Each herb (5g) was added to 600 ml of water and boiled for 30 min. The boiled-down extract was submitted to Bio Medical Laboratories (BML, Inc.Japan), along with blood samples obtained from the enrolled patients. To examine the effects of herbs under the actual conditions of the LTT in the clinical situation, measurement of LTTs were performed as described previously ^<2)>by BML, Inc.LTT for both Toki and Ogon were positive in 12 of 14 patients. LTT for Saiko was positive in all 4 patients and LTT for Kanzo was positive in 3 of 4 patients. No eosinophilia or liver injury was observed in the patients. In the present study, we conducted LTT for these herbs in patients who had taken no Kampo medicine in their life. These findings suggests that LTT for the herbs are likely to yield false-positive results and LTT is unreliable for the diagnosis of Kampo-medicine-induced liver injury.
为了检查汉方药物的促有丝分裂活性对淋巴细胞转化试验(LTT)的实际影响,我们对生活中没有服用汉方药物并首次咨询我科的患者进行了四种草药的LTT。14例患者入组Toki(葛根)和Ogon(葛根),4例患者入组Saiko(柴胡)和Kanzo(葛根)。排除了正在接受皮质类固醇或免疫抑制药物治疗或发生药物过敏的患者。将每种草药(5 g)加入600 ml水中煮沸30 min。将煮沸的提取物与从入选患者中获得的血样一起沿着提交给Bio Medical Laboratories(BML,Inc.Japan)。为了检查草药在临床情况下LTT的实际条件下的效果,如前所述由BML,Inc.进行LTT的测量。14名患者中有12名Toki和Ogon的LTT均为阳性。Saiko的LTT在所有4例患者中均为阳性,Kanzo的LTT在4例患者中的3例中为阳性。在患者中未观察到嗜酸性粒细胞增多或肝损伤。在本研究中,我们对那些一生中没有服用汉方药物的患者进行了这些草药的LTT。这些结果表明,LTT的草药可能会产生假阳性结果和LTT是不可靠的诊断金宝药引起的肝损伤。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
薬物性肝障害の診断基準の作成における問題について
制定药物性肝损伤诊断标准的问题
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    萬谷 直樹
  • 通讯作者:
    萬谷 直樹
漢方薬による肝障害に対する薬物性肝障害診断基準の感度と特異度
药物性肝损伤诊断标准对中药性肝损伤的敏感性和特异性
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    萬谷 直樹;萬谷直樹;萬谷直樹
  • 通讯作者:
    萬谷直樹
漢方薬による肝障害に対する薬物性障害診断基準の感度と特異度
中药肝损伤药源性疾病诊断标准的敏感性和特异性
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K.Yoshimoto;S.Komura;M.Yasuhara;萬谷 直樹
  • 通讯作者:
    萬谷 直樹
Kampo medicine and new criteria for diagnosis of drug-induced liver injury : Sensitivity and Specificity.
汉方医学和药物性肝损伤诊断新标准:敏感性和特异性。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M.Yoshida;A.Akane;M.Nishikawa;H.Tsuchihashi;Mantani N.
  • 通讯作者:
    Mantani N.
Lymphocyte transformation test for medicinal herbs yields false-positive results for first-visit patients
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MANTANI Naoki其他文献

MANTANI Naoki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

From Kampo Medicine to Sustainable Agriculture: Investigating the Allelopathic Properties of Medicinal Plants
从汉方医学到可持续农业:研究药用植物的化感作用
  • 批准号:
    24K18296
  • 财政年份:
    2024
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
High efficiency in the production of second-generation bioethanol by utilizing the fermentation promoting effect of Kampo medicine residue
利用汉方药渣的发酵促进作用高效生产第二代生物乙醇
  • 批准号:
    22H03784
  • 财政年份:
    2022
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Fundamental study on the polypharmacy of Kampo medicine using real-world data
使用真实世界数据对汉方药物的复方药学进行基础研究
  • 批准号:
    22K17373
  • 财政年份:
    2022
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Oxytocin secretion promoting effect of Kampo medicine
汉方药的催产素分泌促进作用
  • 批准号:
    21K07351
  • 财政年份:
    2021
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of host-mediated anti-influenza virus activity of a Kampo medicine and its active ingredients
汉方药物及其活性成分宿主介导的抗流感病毒活性机制
  • 批准号:
    20K07859
  • 财政年份:
    2020
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of sarcopenia preventative kampo medicine based on the epigenetic regulation mechanism of skeletal muscle stem cells.
基于骨骼肌干细胞表观遗传调控机制的肌肉减少症预防汉方药物的开发。
  • 批准号:
    19K22820
  • 财政年份:
    2019
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Epidemiological elucidation of the polypharmacy of Kampo medicine
汉方药复方用药的流行病学阐明
  • 批准号:
    19K24200
  • 财政年份:
    2019
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Identification of target factors for pancreatic cancer metastasis preventive drugs and the evaluation of Kampo medicine
胰腺癌转移预防药物靶标因素的确定及汉方药的评价
  • 批准号:
    19K07153
  • 财政年份:
    2019
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Trial of combined use of Kampo medicine for pneumococcal vaccine therapy-Proposal of a new treatment aiming at enhancement of antibody titer
肺炎球菌疫苗联合使用汉方药的试验-以提高抗体滴度为目标的新疗法的提案
  • 批准号:
    19K07893
  • 财政年份:
    2019
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of anti-RS virus by moatp, the Kampo medicine, and its active ingredients
汉方药moatp及其有效成分的抗RS病毒机制
  • 批准号:
    19K07881
  • 财政年份:
    2019
  • 资助金额:
    $ 0.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了